STERNA BIOLOGICALS
The immune system reacts against parasitic infection and environmental substances like allergens with a type-2 response. While per se a beneficial and protective mechanism, millions of individuals are compromised by a dysregulation of type-2 immunity, suffering from chronic inflammatory conditions like asthma.
STERNA BIOLOGICALS
Social Links:
Industry:
Biotechnology
Founded:
2006-01-01
Address:
Marburg, Hessen, Germany
Country:
Germany
Website Url:
http://www.sterna-biologicals.com
Total Employee:
11+
Status:
Active
Contact:
+49 (0)6421 9830050
Email Addresses:
[email protected]
Total Funding:
22 M EUR
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Google Tag Manager Google Analytics SSL By Default Font Awesome Global Site Tag HSTS
Similar Organizations
Cellestia
Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression.
KBP Biosciences
A multinational clinical stage biotechnology company.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
STipe Therapeutics
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
Turnstone Biologics
Turnstone Biologics is a privately-held clinical stage biotech company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Y Combinator
Y Combinator investment in Venture Round - Sterna Biologicals
Official Site Inspections
http://www.sterna-biologicals.com Semrush global rank: 6.84 M Semrush visits lastest month: 988
- Host name: 178.210.105.81
- IP address: 178.210.105.81
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Sterna Biologicals"
About us - sterna biologicals
Career Working at sterna biologicals We enjoy a modern corporate culture and work environment characterized by diversity, creativity, collaboration, flexibility, agility and performance. We …See details»
Sterna Biologicals - Crunchbase Company Profile & Funding
When was the last funding round for Sterna Biologicals? Sterna Biologicals closed its last funding round on Aug 22, 2022 from a Venture - Series Unknown round. Who are Sterna Biologicals 's …See details»
sterna biologicals GmbH
Clinical Trials associated with sterna biologicals GmbH EUCTR2013-004599-36-DE / Not yet recruiting Phase 2 SB012 for the treatment of active ulcerative colitis (SECURE): a …See details»
sterna biologicals GmbH - LinkedIn
Sterna biologicals GmbH | 544 followers on LinkedIn. Targeting GATA-3 for the treatment of chronic inflammatory diseases | sterna biologicals is a clinical-stage immunology company …See details»
Sterna Biologicals - Innovations- und Gründerzentrum …
Chronic inflammatory diseases are the most significant cause of death in the world with the World Health Organization (WHO) ranking chronic inflammatory diseases as the greatest threat to human health. ... sterna biologicals is the …See details»
Sterna Biologicals - PitchBook
Sterna Biologicals General Information Description. Developer of immunology therapeutics designed for the treatment of chronic inflammatory diseases. The company's therapeutics are developed for asthma, chronic obstructive …See details»
Sterna Biologicals - Contacts, Employees, Board Members
Sterna Biologicals GmbH & Co. KG is an innovative clinical-stage immunology.See details»
Sterna Biologicals - Funding, Financials, Valuation & Investors
Sterna Biologicals GmbH & Co. KG is an innovative clinical-stage immunology. How much funding has this organization raised over time? ShowSee details»
STERNA BIOLOGICALS (STERNA BIOLOGICALS GmbH …
Sterna biologicals startup Clinical-stage immunology company developing novel treatments for chronic inflammatory type 2 diseases such as asthma, ulcerative colitis, chronic obstructive pulmonary disease (COPD) and atopic dermatitis.See details»
News & Events - sterna biologicals
Sterna biologicals announces dosing of first patient in phase IIA proof-of-concept study with SB010 in moderate to severe asthma . Marburg, Germany, December 14, 2021. GIANT-1 …See details»
SB010 (Sterna Biologicals) - life-sciences-europe.com
May 26, 2020 Sterna currently has four programs in phase 2 development. For more information, please visit www.sterna-biologicals.com. CONTACT Christian Pangratz Managing Director …See details»
Sterna Biologicals receives approval for innovative Phase IIA study ...
Sterna biologicals GmbH & Co. KG (sterna), an innovative clinical-stage immunology company developing novel biological treatments for chronic inflammatory diseases, today announced …See details»
sterna biologicals announces strategic corporate update
Jul 17, 2024 sterna biologicals is a clinical-stage immunology company dedicated to harnessing the therapeutic potential of RNA targeting for the treatment of chronic inflammatory diseases. …See details»
Sterna Biologicals Announces Dosing of First Patient in Phase IIa …
Dec 14, 2021 Sterna Biologicals Announces Dosing of First Patient in Phase IIa Proof-of-concept Study with SB010 in Moderate to Severe Asthma. ACCESSWIRE . Tue, Dec 14, …See details»
Company News | sterna biologicals
Jan 7, 2021 sterna biologicals is a clinical-stage immunology company dedicated to harnessing the therapeutic potential of RNA targeting for the treatment of chronic inflammatory diseases. …See details»
Allergen-Induced Asthmatic Responses Modified by a GATA3 …
May 21, 2015 Supported by Sterna Biologicals and by a grant (031A188) from the German Federal Ministry of Education and Research. Disclosure forms provided by the authors are …See details»
SB-020 - Drug Targets, Indications, Patents - Synapse - Patsnap
SB-020: a TBX21 modulators Drug, Initially developed by sterna biologicals GmbH, Now, its global highest R&D status is Pending, Mechanism: TBX21 modulators(T-box transcription …See details»
The GATA-3 approach TREATMENT OF CHRONIC - sterna biologicals
Chronic inflammatory diseases are the most significant cause of death in the world with the World Health Organization (WHO) ranking chronic inflammatory diseases as the greatest threat to …See details»
Pipeline - sterna biologicals
Sterna has successfully completed four phase 2a clinical trials in asthma, ulcerative colitis, COPD and atopic dermatitis. ... sterna biologicals has completed multiple phase IIa clinical trials with …See details»